SPECIAL NOTICE
A -- RRPV Solicitation Summary: Accelerating Near-Term Availability of mRNA-based Pandemic Influenza Vaccine
- Notice Date
- 10/27/2023 9:28:07 AM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- RRPV-24-01-mRNA
- Response Due
- 11/27/2023 12:00:00 PM
- Archive Date
- 12/12/2023
- Point of Contact
- Rebecca Harmon
- E-Mail Address
-
rebecca.harmon@ati.org
(rebecca.harmon@ati.org)
- Description
- This solicitation summary is to notify all potential offerors of a Request for Project Proposals�(RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA), titled, �Accelerating Near-Term Availability of mRNA-based Pandemic Influenza Vaccine.� The full RPP can be accessed through the RRPV website at www.rrpv.org.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/492a413db0d844fbbd295d9e6f28e394/view)
- Record
- SN06869845-F 20231029/231027230047 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |